
News|Articles|June 15, 2021
Process Development Improvements Post-Pandemic
Author(s)Pharmaceutical Technology Editors
What can the biopharma industry learn from its rapid response to the COVID-19 pandemic?
Advertisement
In this expert interview with BioPharm International, James Blackwell, president of The Windshire Group, LLC, explains key actions the biopharma can learn from its response to the COVID-19 pandemic that can be applied to improve process development for non-pandemic development programs.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Oral Solid Dosage Validation Is a Business Continuity Function, Not Just a Compliance Requirement
2
Technology Transfer: Success Drivers and Obstacles Explained
3
Managing Global Trial Supply Risk: Expert Insights
4
How to Vet Importer of Record Partners for Clinical Trials
5




